Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Virology. 2011 Jul 19;417(2):379–384. doi: 10.1016/j.virol.2011.06.021

Fig 1. Treatment effect of S-OIV-3B2 against lethal challenge of swine-lineage H1.

Fig 1

A,B) 6-week old mice (n=5/group) were treated with 12.5 mg/kg doses of S-OIV-3B2 via the intranasal route at 24 h and 72 h before (bc) or after challenge (ac) with 10 MLD50 of ma-Ca/04; C,D) 6-week old mice (n=5/group) were treated with 12.5mg/kg doses of S-OIV-3B2 via the intranasal route at 24 h before or after challenge with 250 TCID50 of SW30. Mock-treated mice received 14 mg/kg doses of control IgG mAb (2B9) at 24 h before challenge. A, C) Percent body weight change; B, D) Percent survival.